DUBLIN--(
BUSINESS WIRE
)--The
"Worldwide Market for Liquid Biopsy, 6th Edition"
report has been added to
ResearchAndMarkets.com's
offering.
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods.
The liquid biopsy market is experiencing significant changes, and The Worldwide Market for Liquid Biopsy, 6th Edition provides an in-depth assessment of the market opportunity from 2023 to 2028. It covers various aspects, including market segmentation by region, different types of liquid biopsy (CTC-based, ctDNA-based, EV and Exosome-based, Multi-Analyte-based, and Other Analytes), and cancer types.
Key applications of liquid biopsy testing in clinical oncology include:
1. Early Detection and Diagnosis/Screening:
Identifying cancer at an early stage.
2. Alternative Testing Method:
When tissue biopsy is challenging or impossible.
When the primary site of metastatic disease is unknown.
3. Therapy Personalization and Monitoring:
Molecular characterization to select optimal therapy.
Monitoring treatment efficacy and adjusting therapy in case of resistance.
4. Disease Monitoring:
Observing disease progression, tumor evolution, residual disease.
Early detection of recurrence.
5. Prognosis of Disease:
Assessing the likely course and outcome of the disease.
Key Market Segments:
By Region:
North America
Europe
Asia
Rest of World
By Type of Liquid Biopsy:
CTC-based Liquid Biopsy
ctDNA-based Liquid Biopsy
EV and Exosome-based Liquid Biopsy
Multi-Analyte-based Liquid Biopsy
Other Analytes Liquid Biopsy
By Type of Cancer:
Breast
Lung
Colorectal
Ovarian
Prostate
Pan-Cancer
Other Cancers
R&D and Selected Tests:
Selected ctDNA-based Liquid Biopsy Tests in Development
Selected CTC-based Liquid Biopsy Tests in 2023
Selected Liquid Biopsy Tests Assessing Multiple Analytes in 2023
The growing acceptance of liquid biopsy, even during the COVID-19 pandemic, underscores its increasing significance in clinical diagnostics. Liquid biopsy's potential in combination with other technologies further contributes to its expanding applications and market growth.
Key Topics Covered:
Chapter One: Executive Summary
Liquid Biopsy Technologies
Industry Structure
Liquid Biopsy Market Revenues and Forecast
Chapter Two: Liquid Biopsy Technologies
Current Major Liquid Biopsy Technologies
Chapter Three: Circulating Tumor DNA (Ctdna) Liquid Biopsy
Advantages and Limitations of Ctdna in Liquid Biopsy
Current Ctdna-based Liquid Biopsy Tests
Biocartis
Biodesix
Cellmax Life
Circulogene
Diacarta
Foundation Medicine (Roche)
Guardant Health
Inivata (Neogenomics)
Lunglife AI
Myriad Genetics
Neogenomics
Oncodna
Personal Genomic Diagnostics (Labcorp)
Qiagen
Resolution Biosciences (Exact Sciences)
Roche Diagnostics
Sysmex-Inostics
Tempus
Ctdna-based Liquid Biopsy Tests in Development
Exact Sciences
Freenome
Grail
Chapter Four: Circulating Tumor Cells (Ctcs) Liquid Biopsy
Challenges in the Development of Ctc-based Liquid Biopsy Tests
Ctc-based Liquid Biopsy Tests
Adaptive Biotechnologies
Angle
Cellmax Life
Epic Sciences
Gilupi
Lunglife AI
Menarini-Silicon Biosystems
Qiagen
Selected Ctc-based Liquid Biopsy Tests in Development
Epic Sciences
Liquid Biotech USA
Chapter Five: Extracellular Vesicles and Other Liquid Biopsy
Liquid Biopsy Tests Based on Extracellular Vesicles / Other Analysts
Aspira Women's Health (Formerly Vermillion)
Biodesix
Exosome Diagnostics
Hologic
Mdxhealth
Extracellular Vesicle/Other Analyst-based Liquid Biopsy Tests in Development
Circulogene
Oncocyte
Resolution Biosciences (Exact Sciences)
Volitionrx
Chapter Six: Multi-Analyst Liquid Biopsy Tests
Liquid Biopsy Tests Based on Multiple Analysts
Biodesix
Foundation Medicine (Roche)
Lunglife AI
Neogenomics
Oncodna
Multiple Analyst-based Liquid Biopsy Tests in Development
Exact Sciences
Freenome
Grail
Lunglife AI
Chapter Seven: Liquid Biopsy Tests for Research Use Only
Liquid Biopsy Tests for Research Use Only
Agena Bioscience
Diacarta
Exosome Diagnostics
Guardant Health
Natera
Qiagen
Chapter Eight: Liquid Biopsy Industry Analysis
Tiers of Competition
Competitive Factors
Significant Market Trends
Personalized Medicine
Increasing Global Life Expectancy
New Liquid Biopsy Products
Increasing Accessibility of Genetic Testing
Regulatory Hurdles
Third-Party Payor Coverage
Demonstrated Clinical Utility
Incidence Rates of Specific Cancers
Competitors No Longer in the Liquid Biopsy Market
Chapter Nine: Liquid Biopsy Market
Market Overview
Market Forecast
Chapter Ten: Market by Analyst
Circulating Tumor DNA
Circulating Tumor Cells
Extracellular Vesicles and Other Analysts
Chapter Eleven: Market by Application
Therapy Guidance and Monitoring
Diagnosis/Screening
Disease Prognosis
Chapter Twelve: Market by Cancer Type
Breast Cancer
Colorectal Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Other Cancers
Pan-Cancer Tests
Chapter Thirteen: Company Profiles
Adaptive Biotechnologies
Agena Bioscience, Inc.
Angle, PLC
Aspira Women's Health
Biocartis Group Nv
Biocept, Inc. (closed)
Biodesix
Cellmax Life
Circulogene
Diacarta, Inc.
Epic Sciences
Epigenomics AG (closed)
Exact Sciences
Exosome Diagnostics, Inc.
Foundation Medicine, Inc. (Roche)
Freenome, Inc.
Gilupi Gmbh
Grail (Illumina)
Guardant Health, Inc.
Hologic
Lunglife AI (Formerly Cynvenio Biosystems)
Menarini-Silicon Biosystems, SPA
Myriad Genetics, Inc.
Natera, Inc.
Neogenomics Laboratories, Inc.
Oncocyte Corporation
Oncodna S.A.
Personal Genome Diagnostics
Qiagen N.V.
Cell-Free DNA Technologies
Ctc Technologies
Exosome And Mirna Technologies
Resolution Biosciences (Agilent)
Roche Diagnostics
Sysmex-Inostics, Inc.
Tempus
Volitionrx
For more information about this report visit
https://www.researchandmarkets.com/r/7c9qdk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.